Diagnostic Approach for Cholangiocarcinoma Using Liquid Bile Biopsy

Launched by UNIVERSITY HOSPITAL, BORDEAUX · May 14, 2024

Keywords

ClinConnect Summary

This clinical trial is studying a new way to diagnose cholangiocarcinoma, a type of cancer that affects the bile ducts. Researchers want to see if they can create a detailed profile using bile samples from patients to identify the disease more accurately. They will compare the results of this new test with standard methods that involve examining tissue samples under a microscope.

To be eligible for this trial, participants need to be at least 18 years old and have a specific condition called bile duct stenosis, which requires certain medical procedures for diagnosis. The trial is not yet recruiting participants, but once it begins, those who take part can expect to provide bile samples, which will help researchers understand if this new approach can improve the accuracy of cholangiocarcinoma diagnoses. It's important to note that pregnant women and those under legal protection cannot participate in this study.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patient 18 years and older
• • Patients with bile duct stenosis who require endoscopy with retrograde papillary catheterization or a radiological procedure for diagnostic purposes (histological samples) as part of their management
• • Oral consent
• Exclusion Criteria:
• • Pregnant woman
• • Patient under legal protection